NCT05546567View on ClinicalTrials.gov

NOPARK Open Label Extension Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions

Safety Issues

Interventions

DIETARY_SUPPLEMENT

Nicotinamide Riboside

1200mg x1 Nicotinamide Riboside

Trial Locations (1)

5021

Haukeland University Hospital, Bergen

All Listed Sponsors

lead

Haukeland University Hospital

OTHER